Osteosarcoma is not about whether it can be treated, but it must be treated. Moreover, the earlier the treatment, the higher the five-year survival rate. Currently, the treatment for osteosarcoma still primarily involves comprehensive therapy centered around surgery. With the advent of neoadjuvant chemotherapy, the five-year survival rate for osteosarcoma has significantly increased. Specifically, once osteosarcoma is diagnosed, extensive chemotherapy is administered before surgery. After chemotherapy, depending on the extent of tumor invasion, either radical segmental resection, limb-sparing surgery, or amputation is considered. Postoperative treatment also requires continued high-dose chemotherapy. In fact, if osteosarcoma is not treated, it metastasizes very quickly, primarily to the lungs. However, if the treatment is very early, timely, and correct, the current five-year survival rate has reached about 80%. Therefore, osteosarcoma can be treated, and the earlier the treatment, the better the outcomes.